NeuroIntact Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Later Stage VC
- Investors
-
3
NeuroIntact General Information
Description
Manufacturer of a brain-cooling medical device intended for patients suffering from traumatic brain injury, stroke, or elevated intracranial pressure. The company's platform develops a targeted temperature management system that enables non-invasive intranasal cooling of the brain to reduce swelling and manage core temperature without systemic side-effects, enabling hospitals and critical-care providers to offer neuroprotection and improved outcomes in neurological emergencies.
Contact Information
Website
www.neurointact.comCorporate Office
- 1100 Wicomico Street
- Suite 330
- Baltimore, MD 21230
- United States
Corporate Office
- 1100 Wicomico Street
- Suite 330
- Baltimore, MD 21230
- United States
NeuroIntact Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 01-Aug-2025 | Completed | Generating Revenue | |||
| 1. Angel (individual) | 01-Jun-2024 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
NeuroIntact Patents
NeuroIntact Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025265909-A1 | Nasal cannula temperature control | Pending | 01-May-2024 | ||
| US-20250339310-A1 | Nasal cannula temperature control | Pending | 01-May-2024 | ||
| WO-2025230829-A1 | Nasal cannula temperature control | Pending | 01-May-2024 | ||
| US-20250339309-A1 | Sensor-based nasal cannula temperature control | Pending | 01-May-2024 | ||
| US-20250339311-A1 | Temperature regulated fluid therapy | Pending | 01-May-2024 | A61F7/12 |
NeuroIntact Signals
NeuroIntact Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Neuvation Ventures | Venture Capital | Minority | ||
| Central Texas Angel Network | Angel Group | Minority | ||
| Riptide Ventures | Angel Group | Minority |
NeuroIntact FAQs
-
When was NeuroIntact founded?
NeuroIntact was founded in 2016.
-
Where is NeuroIntact headquartered?
NeuroIntact is headquartered in Baltimore, MD.
-
What is the size of NeuroIntact?
NeuroIntact has 7 total employees.
-
What industry is NeuroIntact in?
NeuroIntact’s primary industry is Therapeutic Devices.
-
Is NeuroIntact a private or public company?
NeuroIntact is a Private company.
-
What is NeuroIntact’s current revenue?
The current revenue for NeuroIntact is .
-
Who are NeuroIntact’s investors?
Neuvation Ventures, Central Texas Angel Network, and Riptide Ventures have invested in NeuroIntact.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process